Finance

leading-8">H.C. Wainwright has maintained its Neutral rating and $7.00 price target for Kyverna Therapeutics Inc (NASDAQ: KYTX) following the company's recent presentation...

Katherine Haan

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/news/LYNXNPEC95174_L.jpg https://www.investing.com/news/stock-market-news/wells-fargo-downgrades-utilities-to-neutral-after-ytd-rally-432SI-3623524 Investing.com

Kelvin Chan, The Associated Press

expanded crypto offering" for the stock trading company. "Bottom line, we estimate ~10%-12% EPS upside to HOOD earnings if the company were...

;t=b.createElement(e);t.async=!0;t.src=v;s=b.getElementsByTagName(e);s.parentNode.insertBefore(t,s)}(window, document,'script','https://connect.facebook.net/en_US/fbevents.js'); https://i-invdn-com.investing.com/redesign/images/seo/investing_300X300.png https://www.investing.com/news/company-news/sidus-space-partners-with-neuraspace-for-satellite-traffic-management-93CH-3623488 Investing.com